Why would a large biopharmaceutical company collaborate with a smaller innovation company? To reach one ultimate goal: shifting the mold to improve patient outcomes. With the increasing role of real-world data to accelerate the process of bringing drugs to market, treatments have the ability to reach patients faster, and experts are beginning to truly understand the actual impact of how therapies work outside of clinical trials. As a result, this informs how we approach future innovation. You don’t want to miss this discussion on how certain companies working together – big and small – are just as essential as scientific discovery for meeting patient needs across the board.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.